This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Jun 20;316(7148):1842-4.

doi: 10.1136/bmj.316.7148.1842.

Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals

K T Khaw

PMID: 9632398
PMCID: PMC1113355
DOI: 10.1136/bmj.316.7148.1842

Editorial

Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals

K T Khaw. BMJ. 1998.

. 1998 Jun 20;316(7148):1842-4.

doi: 10.1136/bmj.316.7148.1842.

Author

K T Khaw

PMID: 9632398
PMCID: PMC1113355
DOI: 10.1136/bmj.316.7148.1842

No abstract available

PubMed Disclaimer

Comment on

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group.
Michaëlsson K, Baron JA, Farahmand BY, Johnell O, Magnusson C, Persson PG, Persson I, Ljunghall S. Michaëlsson K, et al. BMJ. 1998 Jun 20;316(7148):1858-63. doi: 10.1136/bmj.316.7148.1858. BMJ. 1998. PMID: 9632404 Free PMC article.

Similar articles

On the route to combined evidence from OC and HRT/ERT.
Skouby SO, Jespersen J, Kluft C, Lowe GD, Norris L, Samsioe G, Stevenson J; Writing Group for the 3rd European Conference on Sex Steroids and Cardiovascular Diseases. Skouby SO, et al. Eur J Contracept Reprod Health Care. 2002 Dec;7(4):185-98. doi: 10.1080/713604368. Eur J Contracept Reprod Health Care. 2002. PMID: 12656302 Review. No abstract available.
Postmenopausal hormone replacement therapy: does the progestin make a difference?
Fylstra DL. Fylstra DL. J S C Med Assoc. 2002 Feb;98(1):12-9. J S C Med Assoc. 2002. PMID: 11859600 Review. No abstract available.
[Hormone replacement therapy: curse or blessing?].
Schmidt M, Fink D, Lang U, Kimmig R. Schmidt M, et al. Gynakol Geburtshilfliche Rundsch. 2006;46(4):165. doi: 10.1159/000095724. Gynakol Geburtshilfliche Rundsch. 2006. PMID: 17068400 German.
Health risks after cessation of postmenopausal hormone therapy.
Pines A, Sturdee D, Birkhäuser M; International Menopause Society. Pines A, et al. Climacteric. 2008 Jun;11(3):179-80. doi: 10.1080/13697130802176228. Climacteric. 2008. PMID: 18568782 No abstract available.
[New insights on the effects of hormone replacement therapy on the breast tissue and the orgnaism].
Kubista E. Kubista E. Wien Klin Wochenschr. 2003;115 Suppl 2:46-9. Wien Klin Wochenschr. 2003. PMID: 15518146 Review. German.

See all similar articles

Cited by

Predictors of first hip fracture and mortality post fracture in older women.
Fitzpatrick P, Kirke PN, Daly L, Van Rooij I, Dinn E, Burke H, Heneghan J, Bourke G, Masterson J. Fitzpatrick P, et al. Ir J Med Sci. 2001 Jan-Mar;170(1):49-53. doi: 10.1007/BF03167722. Ir J Med Sci. 2001. PMID: 11440414
Preventing fractures in postmenopausal women with osteoporosis. A review of recent controlled trials of antiresorptive agents.
Hochberg M. Hochberg M. Drugs Aging. 2000 Oct;17(4):317-30. doi: 10.2165/00002512-200017040-00007. Drugs Aging. 2000. PMID: 11087009 Review.
Risk-benefit analysis: from a logical point of view.
Spielthenner G. Spielthenner G. J Bioeth Inq. 2012 Jun;9(2):161-70. doi: 10.1007/s11673-012-9366-y. Epub 2012 Mar 21. J Bioeth Inq. 2012. PMID: 23180259
A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.
Hippisley-Cox J, Pringle M, Crown N, Coupland C. Hippisley-Cox J, et al. Br J Gen Pract. 2003 Mar;53(488):191-6. Br J Gen Pract. 2003. PMID: 14694694 Free PMC article.

References

1. Toozs-Hobson P, Cardozo L. Hormone replacement therapy for all? Universal prescription is desirable. BMJ. 1996;313:350–352. - PMC - PubMed
1. Hemminki E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ. 1997;315:149–153. - PMC - PubMed
1. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273:199–208. - PubMed
1. Nactigall LE, Nachtigall RH, Rachtigall RD, Beckman EM. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979;54:74–79. - PubMed
1. Meade TW, Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull. 1992;48:276. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources